| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/22/2001 | WO2001020002A1 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production |
| 03/22/2001 | WO2001020001A1 Nadph-oxidase thyroid enzyme, nucleic acid coding for same and applications thereof |
| 03/22/2001 | WO2001020000A1 Nucleic acid which is obtained from tetrahymena and which codes for a delta-6-desaturase, the production thereof and use |
| 03/22/2001 | WO2001019998A1 Novel detoxified mutants of escherichia coli heat-labile enterotoxin |
| 03/22/2001 | WO2001019997A2 Basb128 polypeptide and polynucleotide from moxarella catarrhalis |
| 03/22/2001 | WO2001019996A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 03/22/2001 | WO2001019995A1 Plant flowering control genes |
| 03/22/2001 | WO2001019994A2 PLANT APOPTOSIS INDUCING FACTORS (AIFs) |
| 03/22/2001 | WO2001019993A2 Virulence genes of m. marinum and m. tuberculosis |
| 03/22/2001 | WO2001019992A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 03/22/2001 | WO2001019991A1 Compositions and methods for the treatment of immune related diseases |
| 03/22/2001 | WO2001019990A1 Rip-3-like death-associated kinase |
| 03/22/2001 | WO2001019989A2 Method of producing and purifying endostatintm protein |
| 03/22/2001 | WO2001019988A1 Secreted proteins and polynucleotides encoding them |
| 03/22/2001 | WO2001019987A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/22/2001 | WO2001019986A1 Peptide leukotriene receptor |
| 03/22/2001 | WO2001019985A1 Novel receptors and genes encoding the same |
| 03/22/2001 | WO2001019984A1 Rgs8like polypeptide and polynucleotides, a member of the regulators of g protein signalling family of polypeptides |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019982A2 Micro-organisms, their use and method for producing d-amino acids |
| 03/22/2001 | WO2001019981A2 Functional genomics using zinc finger proteins |
| 03/22/2001 | WO2001019980A1 Method for binding nucleic acids to a solid phase |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019975A2 Plants having reduced activity in two or more starch-modifying enzymes |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019969A1 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 03/22/2001 | WO2001019968A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | WO2001019966A2 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019959A1 Improvement of clavulanic acid production |
| 03/22/2001 | WO2001019955A2 Lysosomal targeting pathway enzymes |
| 03/22/2001 | WO2001019953A1 Method of piercing membrane and apparatus therefor |
| 03/22/2001 | WO2001019871A2 Delivery system for antidandruff agent |
| 03/22/2001 | WO2001019870A2 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | WO2001019869A1 Dendritic cell membrane protein cire |
| 03/22/2001 | WO2001019868A1 A novel angiogenesis inhibitor |
| 03/22/2001 | WO2001019867A1 Prion-related protein |
| 03/22/2001 | WO2001019866A1 Dipeptidyl peptidases |
| 03/22/2001 | WO2001019865A1 A novel muskelin and its application and producing method |
| 03/22/2001 | WO2001019864A1 Polynucleotides encoding novel human angiotensin ii-1 receptor proteins and the method of preparation and its use |
| 03/22/2001 | WO2001019862A2 Polypeptides from moraxella (branhamella) catarrhalis |
| 03/22/2001 | WO2001019861A2 Apo-2 receptor antibodies |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019859A2 LEPIDOPTERAN-ACTIVE BACILLUS THURINGIENSIS δ-ENDOTOXIN COMPOSITIONS AND METHODS OF USE |
| 03/22/2001 | WO2001019857A2 Facilitative transporter (ft1 and ft2) from drosophila melanogaster and uses thereof |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019855A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | WO2001019854A2 Neurotransmitter transporter |
| 03/22/2001 | WO2001019853A2 Cell transfection |
| 03/22/2001 | WO2001019851A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 03/22/2001 | WO2001019850A2 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | WO2001019846A1 Transgenically produced fusion proteins |
| 03/22/2001 | WO2001019845A1 Cacna1g polynucleotide, polypeptide and methods of use therefor |
| 03/22/2001 | WO2001019844A1 Altered nucleotide sequence in cd40 ligand promotor |
| 03/22/2001 | WO2001019842A1 Subunit optimized fusion proteins |
| 03/22/2001 | WO2001019517A1 Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same |
| 03/22/2001 | WO2001019485A1 Improved column for dna separation by matched ion polynucleotide chromatography |
| 03/22/2001 | WO2001019482A2 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 03/22/2001 | WO2001019408A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | WO2001019396A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 03/22/2001 | WO2001019393A1 Delivering to eucaryotic cells bacterial proteins that are secreted via type iii secretion systems |
| 03/22/2001 | WO2001019380A2 Oncolytic virus |
| 03/22/2001 | WO2001019379A2 Methods for treating muscular dystrophy with bone marrow cells |
| 03/22/2001 | WO2001019183A2 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2001019161A2 ANTISENSE MODULATION OF TRANSFORMING GROWTH FACTOR-β EXPRESSION |
| 03/22/2001 | WO2001009332A3 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 03/22/2001 | WO2001007636A3 Maize dna ligase ii orthologue and uses thereof |
| 03/22/2001 | WO2001005435A3 Antisense therapy for hormone-regulated tumors |
| 03/22/2001 | WO2001000814A3 Hetero-associating coiled-coil peptides and screenign method therefor |
| 03/22/2001 | WO2001000811A3 17867, a novel human aminopeptidase |
| 03/22/2001 | WO2000078341A8 A method for the prophylaxis and/or treatment of medical disorders |
| 03/22/2001 | WO2000077260A8 Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms |
| 03/22/2001 | WO2000074629A3 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000071693A3 Method for selecting improved vectors |
| 03/22/2001 | WO2000066623A3 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 03/22/2001 | WO2000065038A3 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 03/22/2001 | WO2000060066A8 Protein-protein from s. cerevisiae and methods of using same |
| 03/22/2001 | WO2000058453A3 Plants transformed with thioredoxin |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000051424A3 Genetic modification of somatic cells and uses thereof |
| 03/22/2001 | WO2000046245A8 Human antibiotic proteins |
| 03/22/2001 | WO2000045840A8 Compositions and methods for treating and preventing pathogenic bacterial infection based on the essential role of dna methylation in bacterial virulence |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000029443A9 Contraceptive antibody vaccines |
| 03/22/2001 | WO2000028314A9 Methods and formulations for the separation of biological macromolecules |
| 03/22/2001 | WO2000028056A9 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(AGROBACTERIUM VITIS) |
| 03/22/2001 | WO2000024249A3 Compositions comprising plant cell growth regulating compounds and methods of use thereof |
| 03/22/2001 | WO2000020591A9 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 03/22/2001 | WO2000018421A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 03/22/2001 | WO2000000601A9 Production of low-temperature, salt-and drought-tolerant transgenic cereal plants |
| 03/22/2001 | WO1999061656A3 Agent and method for modulation of cell migration |
| 03/22/2001 | WO1999061605A3 System for reproducing and modulating stability and turnover of rna molecules |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | WO1999050414A9 Blk genes, gene products and uses thereof in apoptosis |
| 03/22/2001 | DE19951715C1 New 18-fluoro-labeled cytosine derivatives, useful as tracers for monitoring activity of transferred cytosine deaminase genes in gene therapy of tumors |
| 03/22/2001 | DE19944402A1 Entwicklung einer effektiven Gentransfertechnik für das Einschleusen von Fremd-DNS in Spermienzellen Development of an effective gene transfer technology for the smuggling of foreign DNA in sperm cells |
| 03/22/2001 | DE10031122A1 Composition for the treatment of malignant diseases comprises agents that reduce concentration of YB-1 protein or inhibit its translocation in tumor cells |